Brief: Caredx Announces Agreement To Divest Lab Products Business To Eurobio Scientific For $170 Million And Announces First Quarter Preliminary Financial Results

CareDx

15/04/2026 22:47

April 15 (Reuters) - CareDx Inc CDNA.O:

CAREDX ANNOUNCES AGREEMENT TO DIVEST LAB PRODUCTS BUSINESS TO EUROBIO SCIENTIFIC FOR $170 MILLION AND ANNOUNCES FIRST QUARTER PRELIMINARY FINANCIAL RESULTS

CAREDX INC - TO DIVEST LAB PRODUCTS BUSINESS TO EUROBIO SCIENTIFIC FOR $170 MILLION CASH

CAREDX INC - EUROBIO SCIENTIFIC GRANTS CAREDX EXCLUSIVE PERPETUAL RIGHT TO DISTRIBUTE IVD TESTS IN NORTH AMERICA

CAREDX INC - PRELIMINARY Q1 2026 REVENUE ABOUT $118 MILLION, UP 39% YEAR-OVER-YEAR

Source text: ID:nBw8vkHDCa

Further company coverage: CDNA.O

 ((Reuters.Briefs@thomsonreuters.com;))